Lisdexamfetamine was approved for medical use in the United States in 2007.[1] A month's supply in the United Kingdom costs the British National Health Service about £58 as of 2019.[update][7] In the United States, the wholesale cost of this amount is about US$264.[10] In 2017, it was the 91st most commonly prescribed medication in the United States, with more than eight million prescriptions.[11][12] It is a Schedule II controlled substance in the United Kingdom and a Schedule II controlled substance in the United States.[7][13]